Monthly Archives: May 2014

Targeted Medical Pharma to Present at the Third Annual Marcum MicroCap Conference

Los Angeles, CA –  May 23, 2014 – Targeted Medical Pharma (OTCQB: TRGM), a leader in the medical food manufacturing sector, announced today that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel. The Company’s presentation by William Shell M.D., Chief Executive Officer and Chief Science Officer, is scheduled to begin at 11:30 a.m. ET. The annual Marcum MicroCap Conference is a signature showcase for superior quality, Continue reading →

Targeted Medical Pharma Looks to China as the Next Medical Food Market

Company discusses distribution of medical foods with large Chinese pharmaceutical company  Los Angeles, May 20, 2014 – Targeted Medical Pharma (OTCQB: TRGM), is currently discussing the logistics of importing the Company’s medical food products into China, with a large Chinese pharmaceutical company. No assurances can be made that a definitive agreement will be consummated between the two Companies at this time. “Growth of international sales and distribution will contribute to the success of our 2014 fiscal initiatives,” said William Shell, M.D. Chief Executive Officer and Continue reading →

Targeted Medical Pharma Reports First Quarter 2014 Financial Results

Los Angeles, CA, May 21, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and markets medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders announced financial results for its first quarter ended March 31, 2014. William Shell, M.D., Chief Executive Officer and Chief Science Officer of Targeted Medical Pharma stated, “During the remainder of 2014 we will continue to focus on the expansion of sales and marketing efforts to increase Continue reading →